STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 43 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,739,000 | +13.5% | 951,600 | +2.1% | 0.43% | -7.9% |
| Q4 2018 | $4,174,000 | -27.0% | 931,600 | -21.0% | 0.47% | -28.4% |
| Q3 2018 | $5,718,000 | +41.4% | 1,179,010 | +74.9% | 0.66% | +17.6% |
| Q2 2018 | $4,044,000 | +1359.9% | 673,996 | +1010.0% | 0.56% | +830.0% |
| Q1 2016 | $277,000 | -80.0% | 60,718 | -66.6% | 0.06% | -70.3% |
| Q4 2015 | $1,382,000 | – | 181,818 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |